These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27227735)

  • 41. Role of (-)-epigallocatechin-3-gallate in cell viability, lipogenesis, and retinol-binding protein 4 expression in adipocytes.
    Sung HY; Hong CG; Suh YS; Cho HC; Park JH; Bae JH; Park WK; Han J; Song DK
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):303-10. PubMed ID: 20711765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
    Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB
    N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver.
    Kim K; Kang JK; Jung YH; Lee SB; Rametta R; Dongiovanni P; Valenti L; Pajvani UB
    Nat Commun; 2021 Mar; 12(1):1822. PubMed ID: 33758172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted Deletion of Adipocyte Abca1 (ATP-Binding Cassette Transporter A1) Impairs Diet-Induced Obesity.
    Cuffe H; Liu M; Key CC; Boudyguina E; Sawyer JK; Weckerle A; Bashore A; Fried SK; Chung S; Parks JS
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):733-743. PubMed ID: 29348118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis.
    Reid BN; Ables GP; Otlivanchik OA; Schoiswohl G; Zechner R; Blaner WS; Goldberg IJ; Schwabe RF; Chua SC; Huang LS
    J Biol Chem; 2008 May; 283(19):13087-99. PubMed ID: 18337240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).
    Flores-Cortez YA; Barragán-Bonilla MI; Mendoza-Bello JM; González-Calixto C; Flores-Alfaro E; Espinoza-Rojo M
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35656886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway.
    Xia M; Liu Y; Guo H; Wang D; Wang Y; Ling W
    Hepatology; 2013 Aug; 58(2):564-75. PubMed ID: 23300015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinol-binding protein 4 : a possible role in cardiovascular complications.
    Mohapatra J; Sharma M; Acharya A; Pandya G; Chatterjee A; Balaraman R; Jain MR
    Br J Pharmacol; 2011 Dec; 164(8):1939-48. PubMed ID: 21585349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulation.
    Hubel E; Fishman S; Holopainen M; Käkelä R; Shaffer O; Houri I; Zvibel I; Shibolet O
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(3):G298-G307. PubMed ID: 34259586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
    Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
    Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance.
    Moraes-Vieira PM; Castoldi A; Aryal P; Wellenstein K; Peroni OD; Kahn BB
    Diabetes; 2016 May; 65(5):1317-27. PubMed ID: 26936962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adipocyte-Specific Deletion of Manganese Superoxide Dismutase Protects From Diet-Induced Obesity Through Increased Mitochondrial Uncoupling and Biogenesis.
    Han YH; Buffolo M; Pires KM; Pei S; Scherer PE; Boudina S
    Diabetes; 2016 Sep; 65(9):2639-51. PubMed ID: 27284109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
    Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
    Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter.
    Chang ML; Chen WT; Hu JH; Chen SC; Gu PW; Chien RN
    Virulence; 2020 Dec; 11(1):1501-1511. PubMed ID: 33135589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus.
    Chen Y; Lv P; Du M; Liang Z; Zhou M; Chen D
    Arch Gynecol Obstet; 2017 Jul; 296(1):53-61. PubMed ID: 28528355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-fat diet-induced adiposity, adipose inflammation, hepatic steatosis and hyperinsulinemia in outbred CD-1 mice.
    Gao M; Ma Y; Liu D
    PLoS One; 2015; 10(3):e0119784. PubMed ID: 25768847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
    Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
    Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.